Infection Control

Infant HAV Immunization Needed for Eradication of Virus

Published in Vaccine Weekly, May 15th, 1995

Infant immunization with hepatitis A virus vaccine will be needed to achieve the ultimate goal of complete eradication, according to a report from Vanderbilt University School of Medicine, Nashville, Tennessee.

In February of 1995 the U.S. Food and Drug Administration approved the first hepatitis A virus (HAV) vaccine for use in the United States. The vaccine, manufactured by SmithKline Beecham Biologicals of Philadelphia, and other HAV vaccines are already in use in 40 other countries.

"Recent field trials have show HAV vaccines to be safe and effective, demonstrating an efficacy of greater than 97 percent for the prevention of disease in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-05-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry